Don C. Jackson, MBA, has extensive experience in the biotechnology and pharmaceuticals sectors, currently serving in multiple roles focused on rare diseases and neurology at argenx, AKCEA Therapeutics, and Mallinckrodt Pharmaceuticals since 2021 and onwards. Jackson has also contributed to the field as a Senior Biopharmaceutical Representative for Amgen since 2017 and held positions at Teva Pharmaceuticals and AstraZeneca, enhancing expertise in respiratory and hospital-based sales. Academic credentials include a Bachelor of Science in Exercise Science from Tulane University and an MBA in Marketing from the University of Phoenix, Augusta, GA campus.
This person is not in any teams
This person is not in any offices